Jan 12, 2026 08:07AM
Jan 12, 2026 08:00AM
Jan 6, 2026 08:00AM
Nov 11, 2025 11:16PM
Nov 11, 2025 11:16PM
Nov 10, 2025 04:01PM
Nov 10, 2025 04:01PM Cogent Biosciences Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2031 and Common Stock
Jul 10, 2025 04:02PM
Jul 10, 2025 04:01PM
Jul 9, 2025 05:59AM
Jul 8, 2025 09:36PM
Jul 8, 2025 04:49PM
Jul 8, 2025 04:26PM
Jan 13, 2025 08:15AM Cogent Biosciences (COGT) Announces Planned 2025 Milestones for Bezuclastinib and Emerging Portfolio of Selective and Potent Targeted Therapeutics
Jan 13, 2025 08:00AM
Jan 8, 2025 08:00AM
Feb 14, 2024 07:04AM
Feb 14, 2024 07:00AM
Jan 9, 2024 08:00AM
Jan 2, 2024 08:00AM
Dec 8, 2023 04:41AM JPMorgan Starts Cogent (COGT) at Overweight
Jun 9, 2023 04:01PM
Jun 7, 2023 05:15AM
Jun 6, 2023 08:25PM
Jun 6, 2023 04:06PM
Jun 6, 2023 04:05PM
Jan 9, 2023 08:19AM
Jan 9, 2023 08:00AM Cogent Biosciences Announces Planned 2023 Milestones for Bezuclastinib and Emerging Portfolio of Selective and Potent Targeted Cancer Therapeutics
Jan 5, 2023 08:00AM
May 7, 2010 09:16AM
Feb 1, 2010 10:38AM
Feb 1, 2010 08:05AM
Dec 22, 2008 07:48AM
Nov 19, 2008 09:49AM
Nov 19, 2008 07:35AM J.P. Morgan Upgrades Cogent (COGT) to Overweight
Nov 17, 2008 05:17PM

276,561 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All